Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_862abd1f07efa37ed6d2ee5ce76ad06c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46f0c951d68f18afc57c063e37348e74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bdfea1f8948897f85c6812593f1e892 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3155069b833b184bcd4ad12f7100dd4c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96466 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57419 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5743 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
filingDate |
2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0eea91f5ec8d879ebed16d033248c729 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8b63a1b6a864ba4bdaaa05c9585bdf6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d600c104f4ba792e46843a268d333919 |
publicationDate |
2012-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2012177684-A2 |
titleOfInvention |
Use of caspase 3 activity and its inhibitors |
abstract |
The present invention provides methods for using the level of caspase 3 activity for determining or prognosticating likelihood of cancer recurrence or relapse in a patient after the treatment for cancer. The present invention also provides methods for treating cancer in a patient using a caspase 3 inhibitor in conjunction with a conventional cancer treatment. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11291705-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3525791-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018069885-A1 |
priorityDate |
2011-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |